DHR Quote, Financials, Valuation and Earnings

Delcath Systems has a net margin of 14.11% compared to Danaher's net margin of 16.64%. Danaher's return on equity of 7.47% beat Delcath Systems's return on equity of -251.36%.

Danaher has a consensus price target of $287.70, signalling upside risk potential of 24.68%. On the other hand Delcath Systems has an analysts' consensus of -- which suggests that it could grow by 88.13%. Given that Delcath Systems has higher upside potential than Danaher, analysts believe Delcath Systems is more attractive than Danaher.

Danaher has a beta of 0.832, which suggesting that the stock is 16.801% less volatile than S&P 500. In comparison Delcath Systems has a beta of 0.851, suggesting its less volatile than the S&P 500 by 14.882%.

Danaher has a quarterly dividend of $0.27 per share corresponding to a yield of 0.46%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Danaher pays 26.2% of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend. Danaher's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Danaher quarterly revenues are $5.8B, which are larger than Delcath Systems quarterly revenues of $11.2M. Danaher's net income of $818M is higher than Delcath Systems's net income of $1.9M. Notably, Danaher's price-to-earnings ratio is 44.04x while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher is 7.21x versus 13.59x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

Quest Diagnostics has a net margin of 14.11% compared to Danaher's net margin of 9.08%. Danaher's return on equity of 7.47% beat Quest Diagnostics's return on equity of 12.68%.

Danaher has a consensus price target of $287.70, signalling upside risk potential of 24.68%. On the other hand Quest Diagnostics has an analysts' consensus of $169.96 which suggests that it could grow by 10.78%. Given that Danaher has higher upside potential than Quest Diagnostics, analysts believe Danaher is more attractive than Quest Diagnostics.

Danaher has a beta of 0.832, which suggesting that the stock is 16.801% less volatile than S&P 500. In comparison Quest Diagnostics has a beta of 0.893, suggesting its less volatile than the S&P 500 by 10.74%.

Danaher has a quarterly dividend of $0.27 per share corresponding to a yield of 0.46%. Quest Diagnostics offers a yield of 1.93% to investors and pays a quarterly dividend of $0.75 per share. Danaher pays 26.2% of its earnings as a dividend. Quest Diagnostics pays out 36.77% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Danaher quarterly revenues are $5.8B, which are larger than Quest Diagnostics quarterly revenues of $2.5B. Danaher's net income of $818M is higher than Quest Diagnostics's net income of $226M. Notably, Danaher's price-to-earnings ratio is 44.04x while Quest Diagnostics's PE ratio is 20.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher is 7.21x versus 1.81x for Quest Diagnostics. Usually stocks with elevated PS ratios are considered overvalued.

Progyny has a net margin of 14.11% compared to Danaher's net margin of 3.64%. Danaher's return on equity of 7.47% beat Progyny's return on equity of 11.31%.

Danaher has a consensus price target of $287.70, signalling upside risk potential of 24.68%. On the other hand Progyny has an analysts' consensus of $30.22 which suggests that it could grow by 29.78%. Given that Progyny has higher upside potential than Danaher, analysts believe Progyny is more attractive than Danaher.

Danaher has a beta of 0.832, which suggesting that the stock is 16.801% less volatile than S&P 500. In comparison Progyny has a beta of 1.350, suggesting its more volatile than the S&P 500 by 34.952%.

Danaher has a quarterly dividend of $0.27 per share corresponding to a yield of 0.46%. Progyny offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Danaher pays 26.2% of its earnings as a dividend. Progyny pays out -- of its earnings as a dividend. Danaher's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Danaher quarterly revenues are $5.8B, which are larger than Progyny quarterly revenues of $286.6M. Danaher's net income of $818M is higher than Progyny's net income of $10.4M. Notably, Danaher's price-to-earnings ratio is 44.04x while Progyny's PE ratio is 25.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher is 7.21x versus 1.26x for Progyny. Usually stocks with elevated PS ratios are considered overvalued.

Star Equity Holdings has a net margin of 14.11% compared to Danaher's net margin of -14.42%. Danaher's return on equity of 7.47% beat Star Equity Holdings's return on equity of -10.13%.

Danaher has a consensus price target of $287.70, signalling upside risk potential of 24.68%. On the other hand Star Equity Holdings has an analysts' consensus of -- which suggests that it could grow by 380.77%. Given that Star Equity Holdings has higher upside potential than Danaher, analysts believe Star Equity Holdings is more attractive than Danaher.

Danaher has a beta of 0.832, which suggesting that the stock is 16.801% less volatile than S&P 500. In comparison Star Equity Holdings has a beta of 0.080, suggesting its less volatile than the S&P 500 by 91.951%.

Danaher has a quarterly dividend of $0.27 per share corresponding to a yield of 0.46%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Danaher pays 26.2% of its earnings as a dividend. Star Equity Holdings pays out 7.62% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Danaher quarterly revenues are $5.8B, which are larger than Star Equity Holdings quarterly revenues of $13.7M. Danaher's net income of $818M is higher than Star Equity Holdings's net income of -$2M. Notably, Danaher's price-to-earnings ratio is 44.04x while Star Equity Holdings's PE ratio is 0.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Danaher is 7.21x versus 0.13x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.